Growth Metrics

Fulgent Genetics (FLGT) Gross Profit (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Gross Profit for 11 consecutive years, with $32.6 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 2.3% to $32.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $130.9 million through Dec 2025, up 22.07% year-over-year, with the annual reading at $130.9 million for FY2025, 22.07% up from the prior year.
  • Gross Profit hit $32.6 million in Q4 2025 for Fulgent Genetics, down from $35.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $285.4 million in Q1 2021 to a low of $13.0 million in Q4 2022.
  • Historically, Gross Profit has averaged $74.3 million across 5 years, with a median of $33.5 million in 2025.
  • Biggest five-year swings in Gross Profit: surged 7620.62% in 2021 and later crashed 93.15% in 2022.
  • Year by year, Gross Profit stood at $189.5 million in 2021, then plummeted by 93.15% to $13.0 million in 2022, then surged by 94.26% to $25.2 million in 2023, then rose by 26.24% to $31.8 million in 2024, then increased by 2.3% to $32.6 million in 2025.
  • Business Quant data shows Gross Profit for FLGT at $32.6 million in Q4 2025, $35.5 million in Q3 2025, and $34.4 million in Q2 2025.